Pheiron is an AI-native biotechnology company, specialized in phenotypic disease characterization and advanced statistical genetics. We envision a future where drug development is deeply rooted in human-level insights, derived directly from real, living individuals. Our platform integrates multi-omic data to generate actionable insights for drug development, targeting high-impact therapeutic programs.